Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2600115919) titled 'A Prospective and Observational Study Evaluating the Efficacy and Safety of Coblopasvir in Combination with Sofosbuvir for the Treatment of Hepatitis C in the Northwest Region' on Jan. 4.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Tangdu Hospital of the Fourth Military Medical University
Condition:
Hepatitis C
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2023-07-05
Target Sample Size: Antiviral treatment group:150;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=271473
Published by HT Digital...